Skip to content
The Kids Research Institute Australia logo

Nasal Delivery of Haemophilus haemolyticus Is Safe, Reduces Influenza Severity, and Prevents Development of Otitis Media in Mice

Despite vaccination, influenza and otitis media (OM) remain leading causes of illness. We previously found that the human respiratory commensal Haemophilus haemolyticus prevents bacterial infection in vitro and that the related murine commensal Muribacter muris delays OM development in mice. The observation that M muris pretreatment reduced lung influenza titer and inflammation suggests that these bacteria could be exploited for protection against influenza/OM.

Citation:
Scott N, Martinovich KM, Granland CM, Seppanen EJ, Tjiam MC, de Gier C, Foo E, Short KR, Chew KY, Fulurija A, Strickland DH, Richmond PC, Kirkham LAS. Nasal Delivery of Haemophilus haemolyticus Is Safe, Reduces Influenza Severity, and Prevents Development of Otitis Media in Mice. J Infect Dis. 2024;230(2):346-56.

Keywords:
Haemophilus haemolyticus; NTHi; influenza; intranasal therapy; otitis media

Abstract:
Despite vaccination, influenza and otitis media (OM) remain leading causes of illness. We previously found that the human respiratory commensal Haemophilus haemolyticus prevents bacterial infection in vitro and that the related murine commensal Muribacter muris delays OM development in mice. The observation that M muris pretreatment reduced lung influenza titer and inflammation suggests that these bacteria could be exploited for protection against influenza/OM.